A Clarification Of Obviousness-Type Double Patenting
In Eli Lilly and Co. v. Teva Parenteral Medicines Inc., the Federal Circuit affirmed the U.S. District Court for the District of Delaware's decision that Eli Lilly's patent to pemetrexed is not invalid...To view the full article, register now.
Already a subscriber? Click here to view full article